Investoreight
Skip to main content

UPDATE 1-Britain to explore wider access to obesity drugs in two-year pilot

Yahoo! Finance
The British government will launch a pilot programme to explore how new injectable weight-loss drugs such as Novo Nordisk's Wegovy can be given to obese patients outside of specialist services in hospitals, it said on Wednesday. The 40 million pound ($50 million) pilot programme follows a move by the country's drug cost-effectiveness watchdog NICE in March to make the weekly shot available to adults with at least one weight-related condition and a body mass index of 35, but only within the stat...
Continue Reading